Glaukos (GKOS) R&D In Process (2017 - 2022)
Historic R&D In Process for Glaukos (GKOS) over the last 4 years, with Q2 2022 value amounting to $10.0 million.
- Glaukos' R&D In Process rose 10000.0% to $10.0 million in Q2 2022 from the same period last year, while for Dec 2022 it was $15.0 million, marking a year-over-year increase of 5000.0%. This contributed to the annual value of $10.0 million for FY2022, which is 0.0% changed from last year.
- Latest data reveals that Glaukos reported R&D In Process of $10.0 million as of Q2 2022, which was up 10000.0% from $5.0 million recorded in Q3 2021.
- In the past 5 years, Glaukos' R&D In Process ranged from a high of $10.0 million in Q2 2022 and a low of $1.5 million during Q3 2019
- Moreover, its 3-year median value for R&D In Process was $5.0 million (2021), whereas its average is $4.7 million.
- Over the last 5 years, Glaukos' R&D In Process had its largest YoY gain of 10000.0% in 2022, and its largest YoY loss of 10000.0% in 2022.
- Glaukos' R&D In Process (Quarter) stood at $1.5 million in 2019, then skyrocketed by 233.33% to $5.0 million in 2021, then surged by 100.0% to $10.0 million in 2022.
- Its last three reported values are $10.0 million in Q2 2022, $5.0 million for Q3 2021, and $5.0 million during Q2 2021.